Chromatin Bioscience and Purespring Therapeutics Partner to Develop Cell-Selective Synthetic Promoters for Next-Generation Gene Therapies

Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a precision nephrology company leading the de...

October 28, 2025 | Tuesday | News
Zai Lab Reports 68% Response Rate for DLL3-Targeted ADC Zocilurtatug Pelitecan in Second-Line Small Cell Lung Cancer

- Robust responses observed in heavily pre-treated patients with a 68% ORR for 1.6 mg/kg in second-line setting -Compelling activity in patients with ...

October 27, 2025 | Monday | Reports
Cytiva Achieves ISCC PLUS Certification for Biobased Resins in Whatman Filtration Devices

Labs will soon have access to filtration products made with ISCC PLUS-certified biobased resins Certified materials enable labs to choose more sustainab...

October 24, 2025 | Friday | News
Merck’s Long-Term OGSIVEO® Data Demonstrate Durable Tumour Reduction, Sustained Symptom Relief, and Consistent Safety in Desmoid Tumour Patients

Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustai...

October 22, 2025 | Wednesday | Reports
BriaCell Partners with Memorial Sloan Kettering to Accelerate Development of Next-Generation Personalized Immunotherapy

Collaboration with MSK’s Therapeutics Accelerator Program includes manufacturing, IND and clinical development support of the Bria-OTS+™ pl...

October 22, 2025 | Wednesday | News
Building Biopharma Resilience — Cytiva’s Pierre-Alain Ruffieux on Balancing Progress and Preparedness

Resilience is no longer a corporate slogan — it’s the new currency of survival in biopharma. As the sector races between scientific breakthroug...

October 20, 2025 | Monday | Interaction
Qualio Introduces AI-Powered Compliance Intelligence to Redefine Life Sciences Regulatory Management

AI-powered gap analysis, continuous compliance monitoring, real-time visibility, and pre-built life sciences frameworks help organizations reduce audit p...

October 15, 2025 | Wednesday | News
Revvity and Profluent Lead the Next Frontier in Gene Editing with AI-Powered Precision

In conversation with BioPharma BoardRoom, Amanda Haupt, Business Unit Manager for Base Editing at Revvity, shares insights into how the com...

October 06, 2025 | Monday | Interaction
Galapagos Cell Therapy Division in Play: Board Eyes Binding Bids Within Weeks

Galapagos announced that its Board of Directors (the “Board”) had decided to explore all strategic alternatives for its cell therapy business...

October 02, 2025 | Thursday | News
VERAXA Biotech and Secarna Pharmaceuticals Form Strategic Alliance to Develop Next-Generation Antibody Oligonucleotide Conjugates

VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH,...

October 01, 2025 | Wednesday | News
Harrow to Acquire Melt Pharmaceuticals, Advancing Non-Opioid, Needle-Free Sedation Therapy MELT-300

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, announced that it has entered into an ag...

September 30, 2025 | Tuesday | News
Philips Unveils Next-Generation CT and Helium-Free MR Systems to Transform Precision and Sustainability in Radiation Therapy

New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term value Philips deb...

September 29, 2025 | Monday | News
Parexel and Paradigm Health Form Strategic Partnership to Transform Clinical Trial Execution with AI-Driven Platform

Parexel, a leading global clinical research organization (CRO), and Paradigm Health, a company rebuilding the clinical research ecosystem, announced a st...

September 16, 2025 | Tuesday | News
Thermo Fisher Scientific Backs Launch of LifeSciKY Covington Life Science Incubator

Thermo Fisher Scientific Inc., the world leader in serving science, proudly announced its role as a founding sponsor of the newly launched LifeSciKY Co...

September 15, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close